retatrutide safety trial ESC 2024: improves lipid and cardiovascular risk profile in Phase II Retatrutide approval: FDA status, clinical

COURAGE to EMBRAZE and BELIEVE Three recent Phase 2 trials focused on helping patients preserve lean mass while losing weight read out recently

~ AlphaMD Published on July 23, 2025 Enclomiphene has become a widely used medication among men seeking to boost natural testosterone production without shutting down the bodys own hormonal feedback loop

In clinical research, meaningful blood pressure reductions were measured after 36 weeks of treatment

A recent open label trial compared the efficacy of drugs currently used to lower ICP in IIH (amiloride, furosemide, spironolactone and topiramate) and found a marginal reduction in ICP with no difference between drugs [11]

For patients with BMI 35 kg/m (regardless of comorbidities) or BMI 30-34.9 kg/m with metabolic disease, bariatric surgery consultation may be appropriate, according to 2022 American Society for Metabolic and Bariatric Surgery guidelines

VerhoeckxKCotterPLpez-ExpsitoIKleivelandCLeaTMackieAet al